Tetronal: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Tetronal}} | |||
== | == Overview == | ||
'''Tetronal''' is a [[sedative]] and [[hypnotic]] drug that belongs to the class of [[barbiturates]]. It was first synthesized in the early 20th century and was used primarily for its calming effects and ability to induce sleep. Like other barbiturates, Tetronal acts on the [[central nervous system]] to produce its effects. | |||
== Chemical Structure == | |||
[[File:Tetronal_structure.svg|thumb|right|Chemical structure of Tetronal]] | |||
Tetronal is chemically known as 5,5-diethyl-2-thioxo-4,6(1H,5H)-pyrimidinedione. The structure of Tetronal includes a pyrimidine ring with two ethyl groups attached at the 5th position and a thioxo group at the 2nd position. This structure is typical of barbiturates, which are derivatives of barbituric acid. | |||
== | == Mechanism of Action == | ||
Tetronal, like other barbiturates, works by enhancing the activity of the [[gamma-aminobutyric acid]] (GABA) neurotransmitter in the brain. GABA is the primary inhibitory neurotransmitter in the [[central nervous system]], and its activation leads to increased [[chloride ion]] influx into neurons, resulting in hyperpolarization and decreased neuronal excitability. This action produces the sedative and hypnotic effects of Tetronal. | |||
Tetronal | == Uses == | ||
Historically, Tetronal was used to treat [[insomnia]], [[anxiety]], and [[seizures]]. However, due to the development of safer and more effective medications, its use has declined significantly. Today, Tetronal is rarely used in clinical practice and is primarily of historical interest. | |||
== | == Side Effects == | ||
The use of Tetronal can lead to several side effects, including [[drowsiness]], [[dizziness]], [[nausea]], and [[respiratory depression]]. In higher doses, it can cause [[coma]] and [[death]] due to its potent depressant effects on the central nervous system. Long-term use can lead to [[tolerance]], [[dependence]], and [[withdrawal symptoms]]. | |||
Tetronal was | == History == | ||
Tetronal was first synthesized in the early 1900s and was one of the many barbiturates developed during that time. It was used extensively until the mid-20th century when [[benzodiazepines]] and other safer sedatives became available. The decline in its use was also due to the high risk of overdose and addiction associated with barbiturates. | |||
== Related pages == | |||
* [[Barbiturate]] | * [[Barbiturate]] | ||
* [[Sedative]] | * [[Sedative]] | ||
* [[Hypnotic]] | * [[Hypnotic]] | ||
* [[ | * [[GABA]] | ||
* [[Central nervous system]] | |||
[[Category:Barbiturates]] | [[Category:Barbiturates]] | ||
[[Category:Sedatives]] | [[Category:Sedatives]] | ||
[[Category:Hypnotics]] | [[Category:Hypnotics]] | ||
Latest revision as of 12:09, 15 February 2025
Overview[edit]
Tetronal is a sedative and hypnotic drug that belongs to the class of barbiturates. It was first synthesized in the early 20th century and was used primarily for its calming effects and ability to induce sleep. Like other barbiturates, Tetronal acts on the central nervous system to produce its effects.
Chemical Structure[edit]
Tetronal is chemically known as 5,5-diethyl-2-thioxo-4,6(1H,5H)-pyrimidinedione. The structure of Tetronal includes a pyrimidine ring with two ethyl groups attached at the 5th position and a thioxo group at the 2nd position. This structure is typical of barbiturates, which are derivatives of barbituric acid.
Mechanism of Action[edit]
Tetronal, like other barbiturates, works by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter in the brain. GABA is the primary inhibitory neurotransmitter in the central nervous system, and its activation leads to increased chloride ion influx into neurons, resulting in hyperpolarization and decreased neuronal excitability. This action produces the sedative and hypnotic effects of Tetronal.
Uses[edit]
Historically, Tetronal was used to treat insomnia, anxiety, and seizures. However, due to the development of safer and more effective medications, its use has declined significantly. Today, Tetronal is rarely used in clinical practice and is primarily of historical interest.
Side Effects[edit]
The use of Tetronal can lead to several side effects, including drowsiness, dizziness, nausea, and respiratory depression. In higher doses, it can cause coma and death due to its potent depressant effects on the central nervous system. Long-term use can lead to tolerance, dependence, and withdrawal symptoms.
History[edit]
Tetronal was first synthesized in the early 1900s and was one of the many barbiturates developed during that time. It was used extensively until the mid-20th century when benzodiazepines and other safer sedatives became available. The decline in its use was also due to the high risk of overdose and addiction associated with barbiturates.
